Literature DB >> 15131843

Multidisciplinary management of lung cancer.

Abdullah Buyukcelik, Bulent Yalcin, Gungor Utkan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15131843

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  12 in total

1.  Transformer 2β (Tra2β/SFRS10) positively regulates the progression of NSCLC via promoting cell proliferation.

Authors:  Lili Ji; Tingting Ni; Yanbo Shen; Qun Xue; Yifei Liu; Buyou Chen; Xuefan Cui; Liting Lv; Xiafei Yu; Yuan Cui; Xiaoning Lu; Jie Chen; Guoxin Mao; Yuchan Wang
Journal:  J Mol Histol       Date:  2014-06-21       Impact factor: 2.611

2.  Elevated RABEX-5 expression predicts poor prognosis in non-small-cell lung cancer.

Authors:  Fuliang Zhang; Yingjie Jia; Fanming Kong; Guohua Hu; Qiling Cai; Tongbai Xu
Journal:  Am J Cancer Res       Date:  2015-08-15       Impact factor: 6.166

Review 3.  Prognostic value of tissue inhibitor of metalloproteinase-2 expression in patients with non-small cell lung cancer: a systematic review and meta-analysis.

Authors:  Lin Zhu; Hong Yu; Shi-Yuan Liu; Xiang-Sheng Xiao; Wei-Hua Dong; Yi-Nan Chen; Wei Xu; Tong Zhu
Journal:  PLoS One       Date:  2015-04-23       Impact factor: 3.240

4.  MiR-204 inhibits human NSCLC metastasis through suppression of NUAK1.

Authors:  L Shi; B Zhang; X Sun; S Lu; Z Liu; Y Liu; H Li; L Wang; X Wang; C Zhao
Journal:  Br J Cancer       Date:  2014-11-20       Impact factor: 7.640

5.  4-cholesten-3-one suppresses lung adenocarcinoma metastasis by regulating translocation of HMGB1, HIF1α and Caveolin-1.

Authors:  Jinben Ma; Guobin Fu; Jing Wu; Shaoxian Han; Lishan Zhang; Ming Yang; Yong Yu; Mengyuan Zhang; Yanliang Lin; Yibing Wang
Journal:  Cell Death Dis       Date:  2016-09-22       Impact factor: 8.469

6.  Increased cell apoptosis in human lung adenocarcinoma and in vivo tumor growth inhibition by RBM10, a tumor suppressor gene.

Authors:  Yunxi Ji; Sheng Xie; Li Jiang; Lijian Liu; Liumei Li; Lichuan Luo; Yan Chen; Jianxuan Zhang; Lei Yu; Yaozhong Zhang; Nong Tang; Bugu Liu
Journal:  Oncol Lett       Date:  2017-08-17       Impact factor: 2.967

7.  Overexpressed LAPTM4B-35 is a risk factor for cancer recurrence and poor prognosis in non-small-cell lung cancer.

Authors:  Fanming Kong; Fangfang Gao; Jun Chen; Yiyu Sun; Ying Zhang; Honggen Liu; Xiaojiang Li; PeiYing Yang; Rongxiu Zheng; Geli Liu; Yingjie Jia
Journal:  Oncotarget       Date:  2016-08-30

8.  Ursolic acid derivative UA232 evokes apoptosis of lung cancer cells induced by endoplasmic reticulum stress.

Authors:  Wenfeng Gou; Na Luo; Huiqiang Wei; Hongying Wu; Xiaojun Yu; Yuqing Duan; Changfen Bi; Hongxin Ning; Wenbin Hou; Yiliang Li
Journal:  Pharm Biol       Date:  2020-12       Impact factor: 3.503

9.  Downregulation of cyclophilin A by siRNA diminishes non-small cell lung cancer cell growth and metastasis via the regulation of matrix metallopeptidase 9.

Authors:  Zhe Qian; Xiaoting Zhao; Mei Jiang; Wenyun Jia; Chunyan Zhang; Yue Wang; Baolan Li; Wentao Yue
Journal:  BMC Cancer       Date:  2012-10-02       Impact factor: 4.430

10.  HER2 induces cell proliferation and invasion of non-small-cell lung cancer by upregulating COX-2 expression via MEK/ERK signaling pathway.

Authors:  Feng Chi; Rong Wu; Xueying Jin; Min Jiang; Xike Zhu
Journal:  Onco Targets Ther       Date:  2016-05-05       Impact factor: 4.147
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.